MedPath

Doxylamine

Generic Name
Doxylamine
Brand Names
Bonjesta, Dalmacol, Dayquil Sinex, Diclectin, Diclegis, Mersyndol, Nyquil Cough, Poly Hist Forte Reformulated Nov 2013, Robafen DM, Robitussin Nighttime Cough DM, Safetussin PM, Unisom, Wal-som (doxylamine)
Drug Type
Small Molecule
Chemical Formula
C17H22N2O
CAS Number
469-21-6
Unique Ingredient Identifier
95QB77JKPL

Overview

Histamine H1 antagonist with pronounced sedative properties. It is used in allergies and as an antitussive, antiemetic, and hypnotic. Doxylamine has also been administered in veterinary applications and was formerly used in parkinsonism.

Indication

用于枯草热、过敏性鼻炎,短期用于失眠。

Associated Conditions

  • Common Cold
  • Insomnia
  • Mild Allergic Rhinitis
  • Nausea
  • Symptoms Flu
  • Vomiting

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
BI-MART
37835-525
ORAL
12.5 mg in 30 mL
5/1/2025
NUVICARE LLC
84324-019
ORAL
6.25 mg in 1 1
5/20/2025
Publix Super Markets Inc
56062-763
ORAL
12.5 mg in 30 mL
5/19/2025
Mylan Pharmaceuticals Inc.
0378-4615
ORAL
10 mg in 1 1
1/3/2019
CVS Pharmacy
69842-899
ORAL
6.25 mg in 1 1
6/18/2025
Lil' Drug Store Products, Inc.
66715-6805
ORAL
6.25 mg in 1 1
6/17/2025
Bryant Ranch Prepack
72162-1485
ORAL
10 mg in 1 1
10/14/2020
Bionpharma Inc.,
69452-206
ORAL
10 mg in 1 1
12/11/2023
Topco Associates LLC
76162-603
ORAL
25 mg in 1 1
3/26/2025
Actavis Pharma, Inc.
0591-2132
ORAL
10 mg in 1 1
10/24/2023

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
DICLECTIN DELAYED RELEASE TABLETS 10MG/10MG
SIN15301P
TABLET, DELAYED RELEASE
10mg
7/20/2017
BONJESTA EXTENDED-RELEASE TABLETS 20 MG/20 MG
SIN16865P
TABLET, FILM COATED, EXTENDED RELEASE
20.0mg
9/18/2023

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
SINUS MEDICATION EXTRA STRENGTH NIGHT TIME
02246847
Tablet - Oral
6.25 MG
12/8/2002
MERCODOL WITH DECAPRYN
aventis pharma inc
02048183
Syrup - Oral
6 MG / 5 ML
12/31/1994
NYQUIL LIQUICAPS
procter & gamble inc
01996215
Capsule - Oral
6.25 MG / CAP
12/31/1993
NYQUIL VAPOCOOL COLD & FLU
procter & gamble inc
02553775
Syrup - Oral
12.5 MG / 30 ML
N/A
NYQUIL COMPLETE
procter & gamble inc
02503549
Syrup - Oral
12.5 MG / 30 ML
7/19/2021
COLD & FLU RELIEF NIGHTTIME
vita health products inc
02306344
Capsule - Oral
6.25 MG
N/A
COLD & SINUS LIQUID CAPSULES
vita health products inc
02427958
Kit ,  Capsule - Oral
6.25 MG
6/1/2016
COLD AND FLU MEDICINE - NIGHT TIME FORMULA
pharmetics (2011) inc
02271672
Capsule - Oral
6.25 MG
4/10/2006
VICKS NYQUIL COUGH
procter & gamble inc
02244662
Liquid - Oral
6.25 MG / 15 ML
8/19/2010
TEVA-DOXYLAMINE/PYRIDOXINE DR
teva canada limited
02304503
Tablet (Delayed-Release) - Oral
10 MG
N/A

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.